Tortoise Investment Management’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Tortoise Investment Management’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2	Closed	-$1	–	820
2023 Q2	$1	Hold	2	–	–	﹤0.01%	775
2023 Q1	$1	Hold	2	–	–	﹤0.01%	778
2022 Q4	$2	Buy	+2	New	+$3	﹤0.01%	773

Tortoise Investment Management's GRNA Position: Q3 2023 in Review

Tortoise Investment Management sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 2 shares — an estimated $1 sold.

Tortoise Investment Management first reported a position in GRNA in Q4 2022 and held it in 3 quarters. The position peaked at $2 in Q4 2022. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

Tortoise Investment Management reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
Tortoise Investment Management sold 2 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $1.
Tortoise Investment Management first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q4 2022 and held it in 3 quarters.
Tortoise Investment Management's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $2 in Q4 2022.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on Tortoise Investment Management's 13F filing for Q3 2023, filed 9 Nov 2023.